Literature DB >> 10082229

The effect of presynaptic catecholamine depletion on 6-hydroxymelatonin sulfate: a double blind study of alpha-methyl-para-tyrosine.

L E Krahn1, S C Lin, G G Klee, P Y Lu, S J Ory, R C Zimmermann.   

Abstract

Because it is a competitive inhibitor of tyrosine hydroxylase, alpha-methyl-para-tyrosine (AMPT) is used to study psychiatric disorders. Melatonin serves as a biological marker of catecholamine function since its secretion is regulated by noradrenergic neurons via beta-adrenergic receptors in the pineal gland. Ten healthy volunteers were administered AMPT in a double-blind placebo controlled study. When subjects received AMPT, nocturnal 6-hydroxymelatonin sulfate (6-SM) decreased significantly as compared with promethazine (night 1 P=0.002; and night 2 P=0.001). Urinary MHPG also decreased on both study days (DF1,9 F=9.82, GG=0.0121). Nocturnal 6-SM excretion and melatonin secretion correlated highly (r=0.91, P=0.0007). Behavioral ratings did not reveal a difference in symptomatology and did not correlate with changes in 6-SM or MHPG. This study demonstrates in healthy controls that 6-SM reliably reflects presynaptic catecholamine depletion induced by AMPT without the emergence of behavioral symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082229     DOI: 10.1016/s0924-977x(98)00006-6

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  2 in total

Review 1.  Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression.

Authors:  Dmytro I Boiko; Anastasiia D Shkodina; Mohammad Mehedi Hasan; Mainak Bardhan; Syeda Kanza Kazmi; Hitesh Chopra; Prerna Bhutra; Atif Amin Baig; Andrii M Skrypnikov
Journal:  Neurochem Res       Date:  2022-06-11       Impact factor: 4.414

Review 2.  Dopaminergic control of cognitive flexibility in humans and animals.

Authors:  Marianne Klanker; Matthijs Feenstra; Damiaan Denys
Journal:  Front Neurosci       Date:  2013-11-05       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.